14 June 2019 - His offer to help negotiate the price of a new J&J depression treatment is narrow in scope and may not even make a difference.

President Donald Trump is finally ready to follow through on his campaign promise to use the government’s power to negotiate drug prices. For one drug, and one agency.

The president offered to help Veterans Affairs secretary Robert Wilkie negotiate the price of a new Johnson & Johnson depression drug at a meeting Wednesday. Trump said he had “read really quite a bit” about the treatment, which he didn’t name but is almost certainly the newly approved ketamine cousin Spravato. He believes it could result in a big drop in veteran suicide.

Read Bloomberg article